AstraZeneca in $560 m deal for respiratory firm
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Join the discussion below, or Read more at Seattle Times.
Since: Apr 13
#1 Jun 10, 2013
This sounds promising.
Add your comments below
|Oyez! Town Crier at Royal Baby Birth Captures A...||8 hr||Anita Bryant s Jihad||1|
|Some beards are crappy because they are||11 hr||geri||1|
|A3 adenosine receptor can activate 'off signals...||Apr 25||bobb||1|
|Bashful? Buy the little blue pill online (May '13)||Apr 19||brianfarrel||13|
|FHA Mortgage Focus Fuels Lend America's Rise (Jan '09)||Apr 17||Now worried||834|
|Viagra may work for women, too (Jul '08)||Apr 16||Xase34||26|
|Genetically Modified Crops May Yield Less Food,...||Apr 16||Bob||1|
Find what you want!
Search Biotech Forum Now
Copyright © 2015 Topix LLC